SCHEMBL7368975

SCHEMBL7368975

CC(=O)CCCCC(=O)Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.56
EPHX2 P34913 1/20 0.54
L3MBTL1 Q9Y468 2/20 0.52
HDAC3 O15379 3/20 0.51
HDAC1 Q13547 3/20 0.51
HDAC2 Q92769 3/20 0.51
HDAC10 Q969S8 3/20 0.51
HDAC11 Q96DB2 3/20 0.51
HDAC8 Q9BY41 3/20 0.51
HDAC6 Q9UBN7 3/20 0.51
NCOR2 Q9Y618 1/20 0.51
ALDH1A1 P00352 2/20 0.51
MAPT P10636 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HDAC4 P56524 2/20 0.50
HDAC7 Q8WUI4 2/20 0.50
HDAC9 Q9UKV0 2/20 0.50
HDAC5 Q9UQL6 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8171576 0.97 RORC (0.59) RORCEPHX2L3MBTL1ALDH1A1MAPT
SCHEMBL8180566 0.90 EPHX2 (0.58) RORCEPHX2L3MBTL1ALDH1A1MEN1
SCHEMBL23054850 0.90 EPHX2 (0.61) EPHX2L3MBTL1HDAC3HDAC1HDAC2
SCHEMBL15480429 0.86 HDAC1 (0.68) EPHX2L3MBTL1HDAC3HDAC1HDAC2
SCHEMBL9539840 0.86 SMN1; SMN2 (0.65) RORCEPHX2L3MBTL1ALDH1A1MAPT
SCHEMBL8179795 0.84 EPHX2 (0.54) EPHX2L3MBTL1HDAC3HDAC1HDAC2
SCHEMBL8180976 0.84 EPHX2 (0.54) EPHX2L3MBTL1HDAC3HDAC1HDAC2
SCHEMBL15480407 0.84 HDAC1 (0.70) HDAC3HDAC1HDAC2HDAC10HDAC11
SCHEMBL29769957 0.84 EPHX2 (0.54) EPHX2L3MBTL1HDAC3HDAC1HDAC2
SCHEMBL5545780 0.84 EPHX2 (0.54) EPHX2L3MBTL1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0478954-B1 Serotonin 5HT1A and 5HT1D agonists MERRELL PHARMA INC (US) 2000-10-18 EP disclosed
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5559143-A Serotonin 5HT1A agonistic method MERRELL PHARMACEUTICALS INC. (US) 1996-09-24 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5387604-A 1,4 benzodioxin derivatives and their use as serotonin 5HT1A agonists MERRELL DOW PHARMACEUTICALS INC. (US) 1995-02-07 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
US-5189179-A SEROTONIN 5HT1A AGONISTS MERRELL DOW PHARMACEUTICALS INC. (US) 1993-02-23 US disclosed
EP-0478954-A1 Serotonin 5HT1A and 5HT1D antagonists MERRELL PHARMACEUTICALS INC. (US) 1992-04-08 EP disclosed
US-4837305-A Derivatives of β-adrenergic antagonists THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1989-06-06 US disclosed
EP-0117089-B1 BETA-ADRENERGIC ANTAGONIST COMPOUNDS AND DERIVATIVES OF BETA-ADRENERGIC ANTAGONISTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1988-12-14 EP disclosed
US-4687873-A Derivatives of β-adrenergic antagonists THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1987-08-18 US disclosed
EP-0117089-A1 Beta-adrenergic antagonist compounds and derivatives of beta-adrenergic antagonists THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1984-08-29 EP disclosed